Skip to main content
Laurus Labs Limited logo

Laurus Labs Limited — Investor Relations & Filings

Ticker · LAURUSLABS ISIN · INE947Q01028 LEI · 335800S8HO8QRYP3VQ26 BSE.NS Manufacturing
Open in API
Filings indexed 707 across all filing types
Latest filing 2020-04-30 Regulatory Filings
Country IN India
Listing BSE.NS LAURUSLABS

About Laurus Labs Limited

https://www.lauruslabs.com/

Laurus Labs Limited is a research-driven organization focused on the development and manufacturing of active pharmaceutical ingredients (APIs), finished dosage forms (FDF), and specialized synthesis services. The company operates across several key therapeutic areas, including anti-retroviral (ARV), oncology, cardiovascular, and anti-diabetic treatments. Through its contract development and manufacturing organization (CDMO) division, it provides integrated drug development solutions to global partners. The company also maintains a biotechnology segment dedicated to recombinant products. Leveraging advanced research and development capabilities alongside large-scale manufacturing infrastructure, the firm emphasizes process chemistry innovation and cost-efficient production to serve diverse global healthcare markets.

Recent filings

Filing Released Lang Actions
Financial Result Updates
Regulatory Filings
2020-04-30 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 70% confidence The document text is extremely short (431 characters) and contains mostly logistical information about a conference call, including dial-in numbers and timing. There is no substantive financial data, no report content, no management discussion, or any other detailed information. The presence of conference call dial-in details strongly suggests this is a Call Transcript or related to a conference call event. Given the lack of actual transcript text, it is likely an announcement or invitation related to a conference call rather than the full transcript. However, since the text is minimal and focused on call logistics, the best fit is Call Transcript (CT) as it aligns with the nature of the content (conference call details). Confidence is moderate due to limited content but clear context.
2020-04-27 English
Board Meeting — Financial Results/Dividend
Regulatory Filings Classification · 100% confidence The document text is extremely short (63 characters) and contains no substantive content, only a placeholder for an omitted picture. There is no financial data, report content, or any descriptive text to classify as a specific report type. Given the lack of content, the document does not fit any specific filing category and defaults to the fallback category for miscellaneous or non-informative filings, which is Regulatory Filings (RNS).
2020-04-24 English
Disclosure under SEBI Takeover Regulations
Regulatory Filings
2020-04-08 English
Updates
Regulatory Filings Classification · 95% confidence The document text contains only placeholders for images and no substantive text or financial data. The true document length is only 166 characters, which is very short and contains no report content. It does not contain any financial statements, regulatory information, or announcements. Given the lack of content, this is likely a Regulatory Filing (RNS) as a fallback category for miscellaneous filings that do not fit other categories.
2020-04-07 English
Trading Window
Regulatory Filings Classification · 95% confidence The document text contains only placeholders for images and no textual content or substantive information. It is extremely short (166 characters) and does not contain any financial data, report titles, or regulatory references. Given the lack of content, it cannot be classified as a report or detailed filing. It is best classified as a Regulatory Filing (RNS) as a fallback category for miscellaneous filings without substantive content.
2020-03-31 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.